AMRX
Price
$7.45
Change
+$0.15 (+2.05%)
Updated
Apr 24, 02:16 PM (EDT)
Capitalization
1.87B
8 days until earnings call
BHC
Price
$5.42
Change
+$0.26 (+5.03%)
Updated
Apr 24, 04:32 PM (EDT)
Capitalization
3.86B
6 days until earnings call
Ad is loading...

AMRX vs BHC

Header iconAMRX vs BHC Comparison
Open Charts AMRX vs BHCBanner chart's image
Amneal Pharmaceuticals
Price$7.45
Change+$0.15 (+2.05%)
Volume$400
Capitalization1.87B
Bausch Health Companies
Price$5.42
Change+$0.26 (+5.03%)
Volume$700
Capitalization3.86B
AMRX vs BHC Comparison Chart
Loading...
AMRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BHC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AMRX vs. BHC commentary
Apr 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMRX is a StrongBuy and BHC is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 24, 2025
Stock price -- (AMRX: $7.30 vs. BHC: $5.17)
Brand notoriety: AMRX: Not notable vs. BHC: Notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: AMRX: 64% vs. BHC: 86%
Market capitalization -- AMRX: $1.87B vs. BHC: $3.86B
AMRX [@Pharmaceuticals: Other] is valued at $1.87B. BHC’s [@Pharmaceuticals: Other] market capitalization is $3.86B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.65B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMRX’s FA Score shows that 1 FA rating(s) are green whileBHC’s FA Score has 1 green FA rating(s).

  • AMRX’s FA Score: 1 green, 4 red.
  • BHC’s FA Score: 1 green, 4 red.
According to our system of comparison, AMRX is a better buy in the long-term than BHC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMRX’s TA Score shows that 6 TA indicator(s) are bullish while BHC’s TA Score has 6 bullish TA indicator(s).

  • AMRX’s TA Score: 6 bullish, 5 bearish.
  • BHC’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, BHC is a better buy in the short-term than AMRX.

Price Growth

AMRX (@Pharmaceuticals: Other) experienced а +1.67% price change this week, while BHC (@Pharmaceuticals: Other) price change was +14.89% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +2.44%. For the same industry, the average monthly price growth was -4.70%, and the average quarterly price growth was -11.48%.

Reported Earning Dates

AMRX is expected to report earnings on Aug 07, 2025.

BHC is expected to report earnings on Jul 30, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+2.44% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BHC($3.86B) has a higher market cap than AMRX($1.87B). AMRX has higher P/E ratio than BHC: AMRX (90.00) vs BHC (13.39). AMRX YTD gains are higher at: -7.828 vs. BHC (-35.856). BHC has higher annual earnings (EBITDA): 2.2B vs. AMRX (400M). BHC has more cash in the bank: 947M vs. AMRX (91.5M). AMRX has less debt than BHC: AMRX (2.75B) vs BHC (22.4B). BHC has higher revenues than AMRX: BHC (8.76B) vs AMRX (2.39B).
AMRXBHCAMRX / BHC
Capitalization1.87B3.86B48%
EBITDA400M2.2B18%
Gain YTD-7.828-35.85622%
P/E Ratio90.0013.39672%
Revenue2.39B8.76B27%
Total Cash91.5M947M10%
Total Debt2.75B22.4B12%
FUNDAMENTALS RATINGS
AMRX vs BHC: Fundamental Ratings
AMRX
BHC
OUTLOOK RATING
1..100
1268
VALUATION
overvalued / fair valued / undervalued
1..100
94
Overvalued
33
Fair valued
PROFIT vs RISK RATING
1..100
48100
SMR RATING
1..100
9699
PRICE GROWTH RATING
1..100
6090
P/E GROWTH RATING
1..100
2197
SEASONALITY SCORE
1..100
75n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BHC's Valuation (33) in the Pharmaceuticals Other industry is somewhat better than the same rating for AMRX (94) in the Pharmaceuticals Major industry. This means that BHC’s stock grew somewhat faster than AMRX’s over the last 12 months.

AMRX's Profit vs Risk Rating (48) in the Pharmaceuticals Major industry is somewhat better than the same rating for BHC (100) in the Pharmaceuticals Other industry. This means that AMRX’s stock grew somewhat faster than BHC’s over the last 12 months.

AMRX's SMR Rating (96) in the Pharmaceuticals Major industry is in the same range as BHC (99) in the Pharmaceuticals Other industry. This means that AMRX’s stock grew similarly to BHC’s over the last 12 months.

AMRX's Price Growth Rating (60) in the Pharmaceuticals Major industry is in the same range as BHC (90) in the Pharmaceuticals Other industry. This means that AMRX’s stock grew similarly to BHC’s over the last 12 months.

AMRX's P/E Growth Rating (21) in the Pharmaceuticals Major industry is significantly better than the same rating for BHC (97) in the Pharmaceuticals Other industry. This means that AMRX’s stock grew significantly faster than BHC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AMRXBHC
RSI
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
78%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
75%
Momentum
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
73%
MACD
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
67%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
72%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
74%
Bearish Trend 2 days ago
76%
Advances
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 10 days ago
74%
Declines
ODDS (%)
Bearish Trend 17 days ago
77%
Bearish Trend 14 days ago
77%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
70%
Aroon
ODDS (%)
Bearish Trend 2 days ago
71%
Bearish Trend 2 days ago
78%
View a ticker or compare two or three
Ad is loading...
AMRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BHC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
FCOM53.711.04
+1.97%
Fidelity MSCI Communication ServicesETF
MMTM231.684.20
+1.85%
SPDR® S&P 1500 Momentum Tilt ETF
QSPT25.960.43
+1.69%
FT Vest Nasdaq-100® Buffer ETF Sep
AUDGBP0.480.00
+0.06%
Australian Dollar - United Kingdom Pound
CNYCAD0.19N/A
N/A
China Yuan - Canadian Dollar

AMRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, AMRX has been loosely correlated with HROW. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if AMRX jumps, then HROW could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMRX
1D Price
Change %
AMRX100%
+0.69%
HROW - AMRX
38%
Loosely correlated
+3.97%
VTRS - AMRX
36%
Loosely correlated
+1.56%
TEVA - AMRX
33%
Poorly correlated
+2.07%
PRGO - AMRX
33%
Poorly correlated
-0.28%
ORGO - AMRX
32%
Poorly correlated
+2.54%
More